Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma

Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma

Despite diagnostic and therapeutic improvements, glioblastoma (GB) remains one of the most threatening brain tumor in adults, underlining the urgent need of new therapeutic targets. Lectins are glycan-binding proteins that regulate several biological processes through the recognition of specific sug...

Full description

Bibliographic Details
Main Authors: Angelica Pace, Fabio Scirocchi, Chiara Napoletano, Ilaria Grazia Zizzari, Luca D’Angelo, Antonio Santoro, Marianna Nuti, Hassan Rahimi, Aurelia Rughetti
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:International Journal of Molecular Sciences
Subjects:
glioblastoma
immunosuppression
C-type lectins
galectins
Siglecs
MGL/CLEC10A
Online Access:https://www.mdpi.com/1422-0067/23/11/6312

Internet

https://www.mdpi.com/1422-0067/23/11/6312

Similar Items